[Federal Register Volume 61, Number 123 (Tuesday, June 25, 1996)]
[Notices]
[Page 32859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-16053]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Correction

    On March 4, 1996, a Notice of Application for Johnson Matthey, Inc. 
(Johnson Matthey), Custom Pharmaceuticals Department, 2003 Nolte Drive, 
West Deptford, New Jersey 08066, was published in the Federal Register 
requesting registration as a bulk manufacturer of Schedules I and II 
controlled substances. See 61 FR 8303. The notice invited that comments 
or objections be filed by May 3, 1996. A correction was subsequently 
published on June 5, 1996, deleting meperidine (9230) from the list of 
controlled substances for which Johnson Matthey made application to 
manufacture in bulk. See 61 FR 28597.
    However, Johnson Matthey does wish to be registered as a bulk 
manufacturer of meperidine. Therefore, meperidine is hereby added to 
the list of controlled substances for which Johnson Matthey made 
application to manufacture in bulk.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture meperidine may file comments or objections to 
the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than August 26, 1996.
    Dated: June 18, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-16053 Filed 6-24-96; 8:45 am]
BILLING CODE 4410-09-M